Nula Therapeutics
PrivateLast Round
Seed
Apr 16, 2026
Total Funding Raised
$30M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Nula Therapeutics operates in Healthcare & Life Sciences and is based in St. Petersburg, Florida. Its latest recorded funding round was a Seed round in April 2026.
Nula Therapeutics is a biotechnology company that develops small-molecule drug candidates targeting the nuclear envelope to treat metabolic dysfunction and age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nula Therapeutics Comparables
Compare Nula Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inipharm | 77% | |
| Roche Holding | 75% | |
| Galilei Biosciences | 70% |
For institutional investors. Book with your work email.
Nula Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 16, 2026 | ||||
| Grant | Feb 24, 2026 |
For institutional investors. Book with your work email.
Nula Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ARPA-H | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 98% MoM.
- Apr 16, 2026
Raised $10M in Seed funding.
For institutional investors. Book with your work email.
Nula Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nula Therapeutics's valuation, stock price, and market status.
Is Nula Therapeutics a public or private company?
Nula Therapeutics is a private company.
What is the current stock price of Nula Therapeutics?
Nula Therapeutics is a private company, so its shares have no public market price. Caplight tracks Nula Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nula Therapeutics worth (valuation)?
Valuation information for Nula Therapeutics is not publicly available.
Can I buy Nula Therapeutics stock?
Nula Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nula Therapeutics's last funding round?
Nula Therapeutics's most recent funding round was Seed on April 16, 2026.
Who are the main investors in Nula Therapeutics?
Key investors in Nula Therapeutics include ARPA-H.
Will Nula Therapeutics IPO soon?
No public IPO plans have been announced for Nula Therapeutics.
How can I track Nula Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Nula Therapeutics's shares on secondary markets.